Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 59, Issue 1, Pages 264-281Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.5b01374
Keywords
-
Categories
Funding
- Ministry of Science and Technological Development of Serbia [172008, 41019]
- Serbian Academy of Sciences and Arts
- Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAUMIC/117060/2010]
- Bill & Melinda Gates Foundation [OPP1040394]
- Fundação para a Ciência e a Tecnologia [PTDC/SAU-MIC/117060/2010] Funding Source: FCT
- Bill and Melinda Gates Foundation [OPP1040394] Funding Source: Bill and Melinda Gates Foundation
Ask authors/readers for more resources
The syntheses and antiplasmodial activities of various substituted aminoquinolines coupled to an adamantane carrier are described. The compounds exhibited pronounced in vitro and in vivo activity against Plasmodium berghei in the Thompson test. Tethering a fluorine atom to the aminoquinoline C(3) position afforded fluoroaminoquinolines that act as intrahepatocytic parasite inhibitors, with compound 25 having an IC50 = 0.31 mu M and reducing the liver load in mice by up to 92% at 80 mg/kg dose. Screening our peroxides as inhibitors of liver stage infection revealed that the tetraoxane pharmacophore itself is also an excellent liver stage P. berghei inhibitor (78: IC50 = 0.33 mu M). Up to 91% reduction of the parasite liver load in mice was achieved at 100 mg/kg. Examination of tetraoxane 78 against the transgenic 3D7 strain expressing luciferase under a gametocyte-specific promoter revealed its activity against stage IV-V Plasmodium falciparum gametocytes (IC50 = 1.16 +/- 0.37 mu M). To the best of our knowledge, compounds 25 and 78 are the first examples of either an 4-aminoquinoline or a tetraoxane liver stage inhibitors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available